Gene · 442908
Papers1,421
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,421
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LINC00662 promotes melanoma progression by competitively binding miR-107 and activating the β-catenin signaling pathway. | Int J Med Sci | 2024 | 38169586 | PubTator, text mining | PubMed |
| The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers. | BMC Cancer | 2024 | 38166752 | PubTator, text mining | PubMed |
| Flavonoids as promising molecules in the cancer therapy: An insight. | Curr Res Pharmacol Drug Discov | 2024 | 38144883 | PubTator, text mining | PubMed |
| Cecal microbiota and mammary gland microRNA signatures are related and modifiable by dietary flaxseed with implications for breast cancer risk. | Microbiol Spectr | 2024 | 38059614 | PubTator, text mining | PubMed |
| LncRNAs-circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers. | Adv Sci (Weinh) | 2024 | 37939296 | PubTator, text mining | PubMed |
| The role of miRNAs in T helper cell development, activation, fate decisions and tumor immunity. | Front Immunol | 2023 | 38264670 | PubTator, text mining | PubMed |
| The role of microRNAs involved in the disorder of blood-brain barrier in the pathogenesis of multiple sclerosis. | Front Immunol | 2023 | 38193092 | PubTator, text mining | PubMed |
| Epigenetic regulation and therapeutic strategies in ulcerative colitis. | Front Genet | 2023 | 38169708 | PubTator, text mining | PubMed |
| CAV1 and KRT5 are potential targets for prostate cancer. | Medicine (Baltimore) | 2023 | 38065913 | PubTator, text mining | PubMed |
| Tumor-associated macrophages: an effective player of the tumor microenvironment. | Front Immunol | 2023 | 38035101 | PubTator, text mining | PubMed |
| A Comprehensive Bioinformatics Approach to Identify Molecular Signatures and Key Pathways for the Huntington Disease. | Bioinform Biol Insights | 2023 | 38033382 | PubTator, text mining | PubMed |
| Downregulated M6A modification and expression of circRNA_103239 promoted the progression of glioma by regulating the miR-182-5p/MTSS1 signalling pathway. | J Cancer | 2023 | 38021156 | PubTator, text mining | PubMed |
| Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study. | BMC Cancer | 2023 | 38012622 | PubTator, text mining | PubMed |
| Function and regulation of miR-186-5p, miR-125b-5p and miR-1260a in chordoma. | BMC Cancer | 2023 | 38012562 | PubTator, text mining | PubMed |
| Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease. | Int J Mol Sci | 2023 | 38003448 | PubTator, text mining | PubMed |
| miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway. | Cancer Biol Ther | 2023 | 37981873 | PubTator, text mining | PubMed |
| Hypoxic BMSC-derived exosomal miR-652-3p promotes proliferation and metastasis of hepatocarcinoma cancer cells via targeting TNRC6A. | Aging (Albany NY) | 2023 | 37976119 | PubTator, text mining | PubMed |
| CD47: The Next Frontier in Immune Checkpoint Blockade for Non-Small Cell Lung Cancer. | Cancers (Basel) | 2023 | 37958404 | PubTator, text mining | PubMed |
| Investigation of risk factors for metachronous recurrence in patients with early gastric adenocarcinoma by miRNA-mRNA integral profiling. | Sci Rep | 2023 | 37952025 | PubTator, text mining | PubMed |
| Circulating levels of miR125a, miR126, and miR146a-5p in patients with obstructive sleep apnea and their relation with markers of endothelial dysfunction. | PLoS One | 2023 | 37917636 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442908/papers?page=3